(Q46625205)

English

Hepatitis B goes globe: Telbivudine as a new treatment option

scientific article published in May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

Hepatitis B goes globe: Telbivudine as a new treatment option (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

author name string

Frank Tacke

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

Christian Trautwein

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

language of work or name

0 references

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

47

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

1786-1787

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

Telbivudine versus lamivudine in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22299

21 January 2018

Management of hepatitis B: summary of a clinical research workshop

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22299

21 January 2018

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22299

21 January 2018

Serum hepatitis B virus DNA level as a risk predictor for liver disease complications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22299

21 January 2018

Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22299

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22299

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of therapy for chronic hepatitis B: progressing from the simple to the complex

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22299

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22299

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18438788

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46625205&oldid=2122762806"